These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 22958892)

  • 1. Familial hypertrophic cardiomyopathy related E180G mutation increases flexibility of human cardiac α-tropomyosin.
    Loong CK; Zhou HX; Chase PB
    FEBS Lett; 2012 Sep; 586(19):3503-7. PubMed ID: 22958892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac dysfunction in hypertrophic cardiomyopathy mutant tropomyosin mice is transgene-dependent, hypertrophy-independent, and improved by beta-blockade.
    Michele DE; Gomez CA; Hong KE; Westfall MV; Metzger JM
    Circ Res; 2002 Aug; 91(3):255-62. PubMed ID: 12169652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-range effects of familial hypertrophic cardiomyopathy mutations E180G and D175N on the properties of tropomyosin.
    Ly S; Lehrer SS
    Biochemistry; 2012 Aug; 51(32):6413-20. PubMed ID: 22794249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistence length of human cardiac α-tropomyosin measured by single molecule direct probe microscopy.
    Loong CK; Zhou HX; Chase PB
    PLoS One; 2012; 7(6):e39676. PubMed ID: 22737252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parvalbumin corrects slowed relaxation in adult cardiac myocytes expressing hypertrophic cardiomyopathy-linked alpha-tropomyosin mutations.
    Coutu P; Bennett CN; Favre EG; Day SM; Metzger JM
    Circ Res; 2004 May; 94(9):1235-41. PubMed ID: 15059934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The flexibility of two tropomyosin mutants, D175N and E180G, that cause hypertrophic cardiomyopathy.
    Li XE; Suphamungmee W; Janco M; Geeves MA; Marston SB; Fischer S; Lehman W
    Biochem Biophys Res Commun; 2012 Aug; 424(3):493-6. PubMed ID: 22789852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. alpha-Tropomyosin mutations Asp(175)Asn and Glu(180)Gly affect cardiac function in transgenic rats in different ways.
    Wernicke D; Thiel C; Duja-Isac CM; Essin KV; Spindler M; Nunez DJ; Plehm R; Wessel N; Hammes A; Edwards RJ; Lippoldt A; Zacharias U; Strömer H; Neubauer S; Davies MJ; Morano I; Thierfelder L
    Am J Physiol Regul Integr Comp Physiol; 2004 Sep; 287(3):R685-95. PubMed ID: 15031138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dilated cardiomyopathy mutant tropomyosin mice develop cardiac dysfunction with significantly decreased fractional shortening and myofilament calcium sensitivity.
    Rajan S; Ahmed RP; Jagatheesan G; Petrashevskaya N; Boivin GP; Urboniene D; Arteaga GM; Wolska BM; Solaro RJ; Liggett SB; Wieczorek DF
    Circ Res; 2007 Jul; 101(2):205-14. PubMed ID: 17556658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreasing tropomyosin phosphorylation rescues tropomyosin-induced familial hypertrophic cardiomyopathy.
    Schulz EM; Wilder T; Chowdhury SA; Sheikh HN; Wolska BM; Solaro RJ; Wieczorek DF
    J Biol Chem; 2013 Oct; 288(40):28925-35. PubMed ID: 23960072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of tropomyosin in the regulation of myocardial contraction and relaxation.
    Wolska BM; Wieczorek DM
    Pflugers Arch; 2003 Apr; 446(1):1-8. PubMed ID: 12690456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional effects of a tropomyosin mutation linked to FHC contribute to maladaptation during acidosis.
    Sheehan KA; Arteaga GM; Hinken AC; Dias FA; Ribeiro C; Wieczorek DF; Solaro RJ; Wolska BM
    J Mol Cell Cardiol; 2011 Mar; 50(3):442-50. PubMed ID: 21047515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural and functional aspects of the myosin essential light chain in cardiac muscle contraction.
    Muthu P; Wang L; Yuan CC; Kazmierczak K; Huang W; Hernandez OM; Kawai M; Irving TC; Szczesna-Cordary D
    FASEB J; 2011 Dec; 25(12):4394-405. PubMed ID: 21885653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-acetylcysteine reverses diastolic dysfunction and hypertrophy in familial hypertrophic cardiomyopathy.
    Wilder T; Ryba DM; Wieczorek DF; Wolska BM; Solaro RJ
    Am J Physiol Heart Circ Physiol; 2015 Nov; 309(10):H1720-30. PubMed ID: 26432840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A familial hypertrophic cardiomyopathy alpha-tropomyosin mutation causes severe cardiac hypertrophy and death in mice.
    Prabhakar R; Boivin GP; Grupp IL; Hoit B; Arteaga G; Solaro RJ; Wieczorek DF
    J Mol Cell Cardiol; 2001 Oct; 33(10):1815-28. PubMed ID: 11603924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Facilitated cross-bridge interactions with thin filaments by familial hypertrophic cardiomyopathy mutations in α-tropomyosin.
    Wang F; Brunet NM; Grubich JR; Bienkiewicz EA; Asbury TM; Compton LA; Mihajlović G; Miller VF; Chase PB
    J Biomed Biotechnol; 2011; 2011():435271. PubMed ID: 22187526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of two familial hypertrophic cardiomyopathy mutations in alpha-tropomyosin, Asp175Asn and Glu180Gly, on the thermal unfolding of actin-bound tropomyosin.
    Kremneva E; Boussouf S; Nikolaeva O; Maytum R; Geeves MA; Levitsky DI
    Biophys J; 2004 Dec; 87(6):3922-33. PubMed ID: 15454401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct, convergent hypersensitivity of calcium-activated force generation produced by hypertrophic cardiomyopathy mutant alpha-tropomyosins in adult cardiac myocytes.
    Michele DE; Albayya FP; Metzger JM
    Nat Med; 1999 Dec; 5(12):1413-7. PubMed ID: 10581085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rescue of tropomyosin-induced familial hypertrophic cardiomyopathy mice by transgenesis.
    Jagatheesan G; Rajan S; Petrashevskaya N; Schwartz A; Boivin G; Arteaga GM; Solaro RJ; Liggett SB; Wieczorek DF
    Am J Physiol Heart Circ Physiol; 2007 Aug; 293(2):H949-58. PubMed ID: 17416600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term rescue of a familial hypertrophic cardiomyopathy caused by a mutation in the thin filament protein, tropomyosin, via modulation of a calcium cycling protein.
    Gaffin RD; Peña JR; Alves MS; Dias FA; Chowdhury SA; Heinrich LS; Goldspink PH; Kranias EG; Wieczorek DF; Wolska BM
    J Mol Cell Cardiol; 2011 Nov; 51(5):812-20. PubMed ID: 21840315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cMyBP-C HCM variant L348P enhances thin filament activation through an increased shift in tropomyosin position.
    Mun JY; Kensler RW; Harris SP; Craig R
    J Mol Cell Cardiol; 2016 Feb; 91():141-7. PubMed ID: 26718724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.